Professor, Internal Medicine, Ohio State University College of Medicine
Infectious Disease
Dr. Susan L. Koletar, MD
|
|
Give Review
Susan L. Koletar is an expert in the field of Infectious Disease. She went to West Virginia University School of Medicine. She received 1 awards: "CMS Meaningful Use Stage 1 Certification". Susan Koletar is a published doctor as well. She has 53 publications published. The latest was: Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immuno... She is registered with Medicare.
Publications
- Highly Active Antiretroviral Therapy Mitigates Liver Disease in HIV Infection.
- Virologic and Serologic Outcomes of Mono vs. Dual HBV Therapy and Characterization of HIV/HBV Coinfection in a US Cohort.
- Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial f...
- Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV/AIDS patients.
- Safety of Varenicline Among Smokers Enrolled in the Lung HIV Study.
- Human N-acetyltransferase 1 *10 and *11 alleles increase protein expression through distinct mechanisms and associate with sulfamethoxazole-induced hypersensitivity.
- Incidence of non-AIDS-defining cancer in antiretroviral treatment-naïve subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized tria...
- Relationship between CD4+ T-cell counts/HIV-1 RNA plasma viral load and AIDS-defining events among persons followed in the ACTG longitudinal linked randomized trials s...
- Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects.
- AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics.
- Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily.
- Nitazoxanide versus metronidazole for Clostridium difficile-associated colitis.
- Third-trimester maternal toxicity with nevirapine use in pregnancy.
- A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human interleukin-2 combined with ...
- Localized osteomyelitis due to Mycobacterium avium complex in patients with Human Immunodeficiency Virus receiving highly active antiretroviral therapy.
- Prevalence of fluconazole-resistant strains of Candida albicans in otherwise healthy outpatients.
- Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362.
- No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT.
- Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients.
- Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.
- Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.
- The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis.
- Evaluation of high-protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial.
- Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir.
- Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio.
- Plasma HIV-1 RNA dynamics in antiretroviral-naive subjects receiving either triple-nucleoside or efavirenz-containing regimens: ACTG A5166s.
- Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression.
- HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients.
- Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell deple...
- Absence of sustained hyperlactatemia in HIV-infected patients with risk factors for mitochondrial toxicity.
- Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy.
- Long-term follow-up of HIV-infected individuals who have significant increases in CD4+ cell counts during antiretroviral therapy.
- Clinical, microbiological, and immunological characteristics in HIV-infected subjects at risk for disseminated Mycobacterium avium complex disease: an AACTG study.
- Cigarette smoking in the HIV-infected population.
- Incidence rate of and factors associated with loss to follow-up in a longitudinal cohort of antiretroviral-treated HIV-infected persons: an AIDS Clinical Trials Group ...
- Topography of cerebellar corticonuclear fibers of the albino rat. Vermis of anterior and posterior lobes.
- Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus.
- Varicella-zoster retinitis in human immunodeficiency virus infection. Case report.
- Cirrhosis: a risk factor for cryptococcal peritonitis.
- Intraorbital injection of amphotericin B for palliative treatment of Aspergillus orbital abscess.
- Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles.
- A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infec...
- In-vitro activity of ciprofloxacin, temafloxacin, azithromycin, clarithromycin and metronidazole against Giardia lamblia.
- Exposure to domestic cats: risk factor for Pasteurella multocida peritonitis in liver cirrhosis?
- Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients.
- Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immuno...
- Azithromycin as treatment for disseminated Mycobacterium avium complex in AIDS patients.
- Refractory mucosal candidiasis in advanced human immunodeficiency virus infection.
- Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, pl...
- Safety reporting in clinical trials.
- A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /l.
- Skin test reactivity and cellular immune responses to Mycobacterium avium sensitin in AIDS patients at risk for disseminated M. avium infection.
Schools
West Virginia University School Of Medicine
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Ohio State University Hospital -
Charleston Area Medical Center - WVSOM -
West Virginia University School of Medicine
Hospital
-
Ohio State University Wexner Medical Center -
Nationwide Children's Hospital
Drug Facts
| NPI NUMBER | 1043226525 | |
| NPPES Provider LastName | KOLETAR | |
| NPPES Provider FirstName | SUSAN | |
| NPPES Provider ZIPCode | 432101240 | |
| NPPES Provider State | OH | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 533.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1043226525 |
| Last Name Of The Provider | KOLETAR |
| First Name Of The Provider | SUSAN |
| View All |
Similar Doctors
|
Dr. Stanley I. Martin, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Christopher K. Lippincott, MD |
|
|
Dr. Thomas C. Keeling, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph M. Gastaldo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christina T. Liscynesky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert E. Leininger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Legesse L. Mekonnen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Ian M. Baird, MB CHB
This Doctor is OpenDoctor Recommended.
|